Released Nov 9, 2026, after the close
10-Q filed Nov 9, 2026, 40 days after period end · 0001193125-26-453585
On November 9, 2026, Annexon, Inc. (the “Company”) announced certain financial results for the third quarter ended September 30, 2026.
The release| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Net Income | -$51.22M | -$54.92M | -$34.82M | -$32.48M |
| EPS Diluted | -$0.25 | -$0.37 | -$0.25 |
Annexon, Inc. · CIK 1528115 · Engraved from SEC EDGAR
| -$0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Annexon reported third quarter 2026 R&D expenses of $41.4 million, compared to $49.7 million a year earlier, and G&A expenses of $10.9 million, compared to $7.3 million.¶2¶3
Net loss attributable to common stockholders was $51.2 million, or $0.25 per share, for the quarter ended September 30, 2026, compared to $54.9 million, or $0.37 per share, a year earlier.¶4
Cash, cash equivalents and short-term investments were $213.4 million as of September 30, 2026, expected to fund operations and anticipated milestones into 2028.¶5
Annexon entered into a strategic credit facility of up to $200 million with Oxford Finance LLC, drawing an initial $50 million at closing.¶6